Positive ONECUT2 expression was significantly correlated with increased tumor number, tumor encapsulation loss, microvascular invasion, poor tumor differentiation, and advanced tumor-node-metastasis (TNM) stage (Table 1) and was predictive of a poor outcome in both HCC cohorts (Supplementary Tables S1 and S2). The gene discussed is ONECUT2; the disease is neoplasm.